ABIONYX Pharma SA (EPA:ABNX)

ABIONYX Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	130	134	41	41	48	68
Market Cap Growth	201.99%	223.58%	-0.54%	-14.37%	-28.38%	178.53%
Enterprise Value	130	134	39	44	49	63
Last Close Price	3.67	3.79	1.19	1.29	1.72	2.44
PS Ratio	31.62	32.57	9.07	8.94	9.23	100.22
PB Ratio	-	-	5.49	5.24	6.76	6.34
P/TBV Ratio	-	-	20.02	16.83	28.22	12.95
EV/Sales Ratio	31.80	32.75	8.60	9.45	9.31	93.31
Debt / Equity Ratio	-	-	0.37	0.43	0.56	0.46
Net Debt / Equity Ratio	-	-	-0.06	-0.09	0.00	-0.28
Net Debt / EBITDA Ratio	-	-	0.11	0.22	0.01	0.51
Net Debt / FCF Ratio	-	-	0.13	0.19	0.01	0.43
Asset Turnover	-	-	0.32	0.30	0.28	0.04
Inventory Turnover	-	-	17.16	21.86	28.49	-
Quick Ratio	-	-	1.49	1.68	1.39	1.86
Current Ratio	-	-	1.58	1.75	1.49	1.93
Return on Equity (ROE)	-	-	-56.76%	-46.62%	-47.14%	-67.28%
Return on Assets (ROA)	-	-	-19.67%	-13.91%	-13.64%	-23.16%
Return on Invested Capital (ROIC)	-176.17%	-156.32%	-62.69%	-47.57%	-55.39%	-228.97%
Return on Capital Employed (ROCE)	-	-	-45.40%	-31.30%	-38.30%	-39.50%
Earnings Yield	-4.24%	-4.12%	-10.62%	-8.48%	-8.68%	-8.61%
FCF Yield	-	-2.17%	-8.97%	-9.16%	-7.27%	-10.14%
Buyback Yield / Dilution	-	-	-14.80%	-4.95%	-12.41%	-5.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.